Syros Pharmaceuticals, Inc. (SYRS) NASDAQ

0.00

+0(+0.00%)

Updated at December 03 04:00PM

Currency In USD

Valuation

Market Cap220.66M
Enterprise Value143.21M
P/E Ratio-0
PEG Ratio-0
Price/Sales Ratio0
Price/Book Ratio-0
Enterprise/Revenue0
Enterprise/EBITDA-0.07

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.35
Return On Equity3.4

Income Statement

Revenue9.94M
Revenue/Share0
Gross Profit7.68M
EBITDA-157.2M
Net Income-164.57M
Diluted EPS-5.81

Balance Sheet

Total Cash58.28M
Total Cash/Share1.48
Total Debt60.23M
Total Debt/Equity-5.41
Current Ratio2.25
Book Value Per Share-0.28

Price History

52-Week Change-99.8
52-Week High0.31
52-Week Low0
Moving Average 50 Days0
Moving Average 200 Days0.02

Statistics

Average Volume37,299
Shares Outstanding26.83M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateSeptember 19, 2022